Date: January 7, 2014
Source: RIKEN
Summary: PET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation.
Innovative Psychiatry
Date: January 7, 2014
Source: RIKEN
Summary: PET molecular imaging of the brain reveals that ketamine may act as an antidepressant by boosting serotonin activity in brain areas involved in motivation.